Semi-Annual Consolidated Statement Of Cash Flows

PhoenixBio Co.,Ltd. - Filing #7297348

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-123,652,000 JPY
63,154,000 JPY
Depreciation
12,044,000 JPY
11,782,000 JPY
Interest expenses
2,599,000 JPY
972,000 JPY
Foreign exchange losses (gains)
14,668,000 JPY
-26,308,000 JPY
Increase (decrease) in provision for bonuses
-4,521,000 JPY
1,798,000 JPY
Decrease (increase) in inventories
21,719,000 JPY
-58,863,000 JPY
Increase (decrease) in trade payables
11,093,000 JPY
-8,492,000 JPY
Other, net
-45,715,000 JPY
62,601,000 JPY
Subtotal
-122,519,000 JPY
4,265,000 JPY
Interest and dividends received
3,778,000 JPY
2,608,000 JPY
Interest paid
-2,599,000 JPY
-972,000 JPY
Income taxes paid
-2,936,000 JPY
-42,978,000 JPY
Net cash provided by (used in) operating activities
-95,184,000 JPY
-33,164,000 JPY
Cash flows from investing activities
Purchase of securities
-223,000 JPY
JPY
Purchase of property, plant and equipment
-4,099,000 JPY
-20,769,000 JPY
Purchase of investment securities
JPY
-8,838,000 JPY
Other, net
JPY
520,000 JPY
Net cash provided by (used in) investing activities
-8,514,000 JPY
124,312,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-39,996,000 JPY
JPY
Net cash provided by (used in) financing activities
-60,338,000 JPY
19,646,000 JPY
Effect of exchange rate change on cash and cash equivalents
-16,262,000 JPY
56,572,000 JPY
Net increase (decrease) in cash and cash equivalents
-180,300,000 JPY
167,367,000 JPY
Cash and cash equivalents
1,204,590,000 JPY
1,384,891,000 JPY
1,722,690,000 JPY
1,555,323,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.